The increased expression of genes related to ECM degradation (e.g., Mmp14 and Adamts4) is consistent with previous findings showing that glucose-induced advanced glycation end products (RAGE) mediate modification of the components of the ECM and accelerate atherosclerosis under diabetic conditions (46–49). The gene discussed is ADAMTS4; the disease is atherosclerosis.